What Атлас does

Атлас (Atlas) is a Russian biomedical holding company founded in 2013 and headquartered in Moscow, operating under the legal entity OOO «БиоТех Решения» (BioTech Resheniya). The company sells direct-to-consumer genetic and microbiome tests through its e-commerce site atlas.ru and a network of B2B partners, with cumulative usage stated at 50,000+ customers. Its core portfolio consists of three at-home test products: a Genetic Test genotyping approximately 660,000 variants on Illumina microarrays, a premium Full Genome (WGS) test covering 590+ million variants, and a Microbiome Test using metagenomic sequencing on Illumina MiSeq. A subsidiary, Solo, provides molecular oncology diagnostics, and an upload.atlas.ru service interprets raw genetic data from third-party providers such as 23andMe, Dante Labs, and MyHeritage for global customers.

The underlying technology stack combines Illumina laboratory platforms with proprietary bioinformatics and a seven-stage quality control process. Results are continuously updated as new scientific research is incorporated, with 120,000+ scientific publications and 154 population reference datasets informing interpretation. The company monetizes one-time test purchases (Genetic Test, WGS, Microbiome Test), third-party data interpretation, and 30-minute geneticist consultations, and operates a B2B partner program that pays commission (up to 10,000 rubles per sale) to clinics, nutritionists, and fitness trainers who recommend Atlas tests. Free email courses and a content blog function as top-of-funnel lead generation, while a mobile app, Telegram bot, and integration with Yandex Pay / Yandex Delivery complete the digital distribution stack.

Atlas is the only Russian platform that combines DNA and gut microbiome analysis in a single personal account, a positioning that has earned it a 2021 Nutra Ingredients Award and 12 years of category presence. The company appears to be privately held and founder-led, with no disclosed funding rounds or institutional investors, and operates under Russian Federal Law 152-FZ on personal data with data stored domestically on certified protected servers. The market served is primarily Russian, with international exposure limited to the upload.atlas.ru data interpretation service.

Name

Атлас

Legal name

Obshchestvo s ogranichennoy otvetstvennostyu «BioTeh Resheniya» (Общество с ограниченной ответственностью «БиоТех Решения»)

Website

https://atlas.ru

Company type

Private

Founded year

2013

Operating status

Operating

Headcount range

251–500 employees

Short description

Атлас (Atlas) is a Moscow-based biomedical holding founded in 2013 that sells direct-to-consumer genetic, whole-genome, and gut microbiome tests in Russia via atlas.ru, supported by a B2B partner program, a Solo oncology diagnostics subsidiary, and an international data-interpretation service for third-party raw genetic files.

Ownership category

akta.pro rank

Product category

Direct-to-Consumer Genetic Testing

NAICS

Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215), Medical and Diagnostic Laboratories (62151)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics) (HLAAALAD)

akta.pro secondary industries

Molecular Diagnostics & Genomics Laboratories (HLAFAMAE), Genetic & Prenatal Testing Laboratories (HLAFAMAH)

Keywords

• Genetic testing services
• Microbiome analysis
• DNA sequencing
• Direct-to-consumer health
• Personalized medicine

Headquarters

HQ city

Москва, Центральный Федеральный Округ

HQ country

Russia

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain, Infrastructure

Revenue model

1. Genetic Test (DNA): One-time purchase of a genetic test kit with analysis and interpretation of approximately 660,000 genetic variants covering health risks, nutrition, sports, ancestry, and other traits. Results delivered in personal account. Sample collection via cheek swab at home.
2. Full Genome Test (WGS): Premium one-time purchase test analyzing more than 590 million genetic variants (95%+ of genome). Includes oncological risks, pharmacogenetics, and expanded health/nutrition/sports information. Results are usable for decades.
3. Microbiome Test: One-time purchase test for gut microbiome analysis. Includes protection from 5 diseases, vitamin synthesis potential, fiber breakdown, and personalized nutrition recommendations. Company recommends repeating every 3 months for progress tracking.
4. Third-Party Data Interpretation: Interpretation of raw genetic data from other testing services (23andMe, Genotek, etc.) starting at 9,900 rubles for genetic test data and 17,900 rubles for full genome data.
5. Geneticist Consultation: Online consultation (phone or Zoom) with a genetics specialist, 30 minutes, priced at 3,500 rubles for genetic test results and 10,000 rubles for full genome/exome results.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels7 records

Core offering

Атлас (Atlas) sells at-home DNA genetic testing and gut microbiome analysis kits to Russian consumers and partner clinics. The company processes biological samples (cheek swabs or stool) in Illumina-certified laboratories using proprietary bioinformatics, then delivers personalized reports on disease risks, pharmacogenetics, nutrition, sports, and ancestry through a personal account on web and mobile. The company also offers third-party genetic data interpretation, geneticist consultations, and oncology diagnostics via its Solo subsidiary.

Product overview

Atlas (ООО «БиоТех Решения») is a Russian biomedical holding founded in 2013 offering a portfolio of genetic and microbiome testing products. The core products are three distinct tests: the Генетический тест (Genetic Test), analyzing ~660,000 variants via Illumina microarray; the Полный геном (Whole Genome), sequencing >95% of the genome (~590 million variants); and the Тест микробиоты (Microbiome Test), profiling gut bacteria via DNA sequencing. These are complemented by an Интерпретация данных (Data Interpretation) add-on service that accepts and interprets raw files from third-party genetic tests (23andMe, Dante Labs, MyHeritage, FamilyTreeDNA, and others), and a Консультация генетика (Geneticist Consultation) for result review. Educational offerings include four email courses — Правильное питание (nutrition), Мой счастливый кишечник (microbiome), Заботливый курс о стрессе (stress management), and О здоровье пищеварения (digestive health). Satellite services include Онкодиагностика (Solo) for oncology diagnostics and Генетика для профессионалов for clinic/fitness-professional partners.

Differentiator

Problem solved

Functional benefit

Brands

• Solo (Соло): Oncology diagnostics service providing molecular tests for cancer patients to help select the most effective treatment even in complex cases.
• Atlas Clinic
• Atlas Pro

Products and services

• Genetic Test (Генетический тест) At-home DNA genotyping test analyzing approximately 660,000 genetic variants via Illumina microarray, with at-home cheek swab sample collection and a personalized report covering disease risks, hereditary conditions, nutritional traits, sports performance, ancestry, and pharmacogenetics, delivered through the Atlas personal account.
• Full Genome Test (Полный геном) Premium whole-genome sequencing test analyzing more than 95% of the genome (590+ million genetic variants), with reports covering oncology syndromes, pharmacogenetics for 96 drugs, 368 hereditary diseases, expanded health/nutrition/sports information, ancestry with haplogroups, and migration maps, intended to remain usable for decades.
• Microbiome Test (Тест микробиоты) At-home gut microbiome test using metagenomic DNA sequencing to assess bacterial diversity, fiber breakdown, vitamin synthesis potential (8 vitamins), protection against 5 diseases (obesity, Crohn's disease, type 2 diabetes, ischemic heart disease, ulcerative colitis), and to deliver personalized nutrition recommendations, with results updated as new research emerges; recommended for repetition every 3 months.
• Data Interpretation Service (Интерпретация данных) Interpretation service for raw genetic data files from third-party providers including 23andMe, Genotek, Dante Labs, DNKOM, Genomed, Genetico, Nebula Genomics, MyHeritage, and FamilyTreeDNA, accepting VCF, TXT, FASTQ (gzip, 100+ gigabases), and BAM/CRAM (≥30x coverage) formats, with Atlas-format results delivered in the personal account.
• Geneticist Consultation (Консультация генетика) 30-minute online consultation with a genetics specialist, conducted by phone or Zoom, to explain test results, discuss disease risks, hereditary conditions, pharmacogenetics, and family planning implications, priced at 3,500 rubles for genetic test customers and 10,000 rubles for full genome / exome customers.
• Solo Oncology Diagnostics (Онкодиагностика) Molecular oncology tests operated by the Solo subsidiary at solo.atlas.ru, helping cancer patients and their physicians identify the most effective treatment options even in complex cases.

Quantifiable outcome

• 590+ million genetic variants analyzed in Full Genome test (vs ~660,000 in standard genetic test vs <0.1% in typical tests)
• +4 more outcomes

Named customers6 records

Segments5 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

Feature6 records

Partnerships

One partnership is on record.

• IlluminacoreTechnology or IntegrationAtlas uses Illumina technology for DNA and gut microbiome analysis. Illumina is described as the market leader in molecular research technologies. The analysis is performed in certified laboratories. Illumina provides DNA microarray chips for the genetic test and sequencing platforms (MiSeq) for the microbiome test.

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Ancestry (AncestryDNA): Largest global D2C ancestry DNA testing brand; Atlas's 154-population ancestry offering and 8th-degree relative finder are explicitly benchmarked against Ancestry's value proposition.
• Nebula Genomics: D2C whole genome sequencing company focused on deep genomic data and privacy; Atlas's upload.atlas.ru explicitly accepts Nebula raw files, indicating close product overlap.
• 23andMe: Pioneer US D2C genetic testing company covering health risks, ancestry, and traits; Atlas accepts 23andMe raw data files for interpretation, making it both a partner and competitive benchmark.
• Dante Labs: Direct-to-consumer whole genome sequencing provider; offers the same 95%+ genome coverage and pharmacogenetic reporting that Atlas's Full Genome product competes against.
• Viome: D2C gut microbiome testing and personalised nutrition recommendations — the closest international analogue to Atlas's microbiome product, including retest-driven personalised diet plans.
• MyHeritage DNA: Global D2C genetic testing service with strong ancestry and relative-finding capabilities; one of the third-party providers whose raw data Atlas interprets.
• Genotek (Генетика): Leading Russian D2C genetic testing provider offering DNA tests for health, ancestry, and pharmacogenetics — directly comparable D2C genomics competitor in Atlas's home market.

Emerging players

• DayTwo: Microbiome-based personalised nutrition platform with both D2C and B2B healthcare channels; comparable technology stack (gut sequencing + AI-driven nutrition recommendations) but smaller consumer brand.
• DNAfit: D2C fitness and nutrition genetics company using Illumina microarrays; a smaller international peer overlapping with Atlas's sports-injury-risk and metabolism reporting.

Broad incumbents

• Color Genomics: Clinical-grade genetic testing platform spanning hereditary cancer, pharmacogenomics, and population health; comparable high-volume WGS workflows but positioned as a B2B/clinical incumbent rather than D2C.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat7 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xt.me/atlas_gentestbot
• LinkedInlinkedin.com/company/%D0%B0%D1%82%D0%BB%D0%B0%D1%81

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Атлас